Nozomu Kamei
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
High-normal levels of B-type natriuretic peptide are associated with chronic kidney disease progression independent of albuminuria in individuals with diabetes: an observational cohort study.
Journal: Diabetes research and clinical practice
Published: January 24, 2026
Refining the Cardiovascular-Kidney-Metabolic Staging System for Improved Risk Stratification of Chronic Kidney Disease Progression in Type 2 Diabetes.
Journal: Circulation reports
Published: January 05, 2026
The health stage of cardiovascular-kidney-metabolic (CKM) syndrome is useful for predicting all-cause mortality in patients with type 2 diabetes: a cohort study in a period prior to the standard use of recent pharmacotherapy.
Journal: Journal of diabetes and its complications
Published: July 03, 2025
Association of the Glycated Albumin-to-Glycated Haemoglobin Ratio With Mortality in Type 2 Diabetes: A Retrospective Cohort Analysis.
Journal: Endocrinology, diabetes & metabolism
Published: April 25, 2025
Effectiveness of the presence of diabetologists for perioperative complications in patients with diabetes undergoing colorectal cancer surgery: A nationwide inpatient database in Japan.
Journal: Journal of diabetes investigation
Published: March 18, 2025
Association among circulating erythropoietin-producing hepatoma A2, progranulin, and kidney function in individuals with diabetes.
Journal: Journal of diabetes investigation
Published: March 07, 2025
Association of Difference Between eGFR From Cystatin C and Creatinine and Serum GDF-15 With Adverse Outcomes in Diabetes Mellitus.
Journal: Journal of cachexia, sarcopenia and muscle
Published: December 29, 2024
Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial.
Journal: Cardiovascular diabetology
Published: December 11, 2024
Urinary fatty acid-binding protein 4 is a promising biomarker for glomerular damage in patients with diabetes mellitus.
Journal: Journal of diabetes investigation
Published: September 21, 2024
Elevated urinary fatty acid-binding protein 4 level predicts future renal dysfunction and poor prognosis in Japanese patients with diabetes: a longitudinal cohort study.
Journal: Clinical kidney journal
Published: August 30, 2024
Associations between circulating levels of FABP4 and TNF receptors are more evident in patients with type 2 diabetes mellitus than in patients with type 1 diabetes mellitus.
Journal: Endocrine connections
Published: July 11, 2024
Last Updated: 09/26/2026